The DOI matches its Crossref record.
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 20
- Silveberg, 1989, Cancer statistics, 1989, CA, 39, 3
- Buyse, 1988, Adjuvant therapy of colorectal cancer: why we still don't know, JAMA, 259, 3571, 10.1001/jama.1988.03720240033031 · DOI · Paper page
- Wolmark, 1988, Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01, J Natl Cancer Inst, 80, 30, 10.1093/jnci/80.1.30 · DOI · Paper page
- Laurie, 1989, Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil, J Clin Oncol, 7, 1447, 10.1200/JCO.1989.7.10.1447 · DOI · Paper page
- Moertel, 1990, Levamisole and fluorouracil for adjuvant therapy of resected colon cancer, N Engl J Med, 322, 352, 10.1056/NEJM199002083220602 · DOI · Paper page
- National Institutes of Health Consensus Development Conference Statement, 1990
- Grem, 1987, Overview of current status and future directions of clinical trials with 5-Fluorouracil in combination with folinic acid, Cancer Treat Rep, 71, 1249
- Advanced Colorectal Cancer Meta-analysis Project, 1992, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate, J Clin Oncol, 10, 896, 10.1200/JCO.1992.10.6.896 · DOI · Paper page
- Miller, 1991, Preplanned meta-analyses in a clinical trial aimed at reducing frailty and injuries in older persons, Controlled Clin Trials, 12, 630, 10.1016/0197-2456(91)90106-V · doi:10.1016/0197-2456(91)90106-v
- Zee, 1993, Salvaging clinical trials forced to terminate early by results of external information, Controlled Clin Trials, 15, 439, 10.1016/0197-2456(93)90163-8 · doi:10.1016/0197-2456(93)90163-8
- Pater, 1994, Timing the collaborative analysis of three trials comparing 5-FU plus folinic acid (FUFA) to surgery alone in the management of resected colorectal cancer: a National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) perspective, Stat Med, 13, 1337, 10.1002/sim.4780131307 · doi:10.1002/sim.4780131307
- Zaniboni, 1993, FUFA increases disease-free survival (DFS) in resected B2C colon cancer (CC): results of a prospective pooled analysis of 3 randomised trials (RCTs), Proc Am Soc Clin Oncol, 12, 555
- Lachin, 1986, Evaluation of sample size and power analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification, Biometrics, 42, 507, 10.2307/2531201 · DOI · Paper page
- Francini, 1994, Folinic acid 5-fluorouracil as adjuvant chemotherapy in colon cancer, Gastroenterology, 106, 899, 10.1016/0016-5085(94)90748-X · DOI · Paper page
- Wolmark, 1993, The benefit of leucovorin- modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from the National Surgical Adjuvant Breast and Bowel Project protocol C-03, J Clin Oncol, 11, 1879, 10.1200/JCO.1993.11.10.1879 · DOI · Paper page
- O'Connell, 1993, An intergroup trial of intensive course 5FU and low dose leucovorin as surgical adjuvant therapy for high risk colon cancer, Proc Am Soc Clin Oncol, 12, 552
- Moertel, 1992, The intergroup study of fluorouracil (5-FU) and levamisole (LEV) as adjuvant therapy for stage C colon cancer, Proc Am Soc Clin Oncol, 11, 457
- Commentary, 1989, 5-FU and leucovorin as adjuvant treatment for colon cancer 1989, Clin Oncol Alert, 8, 84
- US Department of Health Human Services, 1990, FDA Drug Bulletin, 20, 4
- Gray, 1991, Axis: a suitable case for treatment, Br J Cancer, 63, 841, 10.1038/bjc.1991.187 · doi:10.1038/bjc.1991.187
Cited by
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
Japanese Society for Cancer of the Colon and Rectum, Watanabe, T., Muro, K., Ajioka, Y., Hashiguchi, Y., Ito, Y., Saito, Y., Hamaguchi, T., Ishida, H., Ishiguro, M., et al. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1101-6 · Cited by 2,467
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Metadata
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1995-04
- Volume
- 345
- Issue
- 8955
- Pages
- 939-944
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2469345929
- Cited by
- 1,066
- References
- 0
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. https://app.cochat.ai/papers/10.1016/s0140-6736(95)90696-7
- The paper
- Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. (1995). The Lancet. https://doi.org/10.1016/s0140-6736(95)90696-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
